Benefits and Risks of Colorectal Cancer Screening

作者: Jürgen F. Riemann , Carsten Schröder , Maria Kallenbach , Klaus Giersiepen , Hans-Joachim Schmoll

DOI: 10.1159/000364886

关键词:

摘要: sary diagnostic and therapeutic steps of all examination modalities, the indications for general CRC screening, risk situations, as well necessary follow-up intervals after diagnosis resection [4]. In most cases, develops via precursor lesions, socalled polyps or adenomas, progression which through accumulation genetic changes is known (adenomacancer sequence). An important fact that these tumors grow slowly over 10–15 years, because this time frame due to process growth into lumen gut, they can be easily detected fecal analysis (occult blood test) by endoscopy (colonoscopy) with possibility immediate lesions early cancers. Recent investigations have demonstrated especially in right-sided colon there are subgroups polyps, so-called serrated faster [5]. Since 2002 Germany, an enhanced but still opportunistic prevention detection program exists both sexes, includes guaiac-based occult test (gFOBT) beginning 50th year age screening colonoscopy 55th age. The stool offered annually up year, case refusal every 2 years 56th year. Screening repeated 10 inconspicuous initial colonoscopy. basis implementation validation gFOBT was formed a number large randomized studies long-term highest evidence level 1A. According studies, it accepted annual biennial use significant reduction incidence approximately 20% achieved [6–8]. Colorectal Cancer Screening: Pro Jurgen F. Riemann (Ludwigshafen)

参考文章(57)
J H Scholefield, S M Moss, C M Mangham, D K Whynes, J D Hardcastle, Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up Gut. ,vol. 61, pp. 1036- 1040 ,(2012) , 10.1136/GUTJNL-2011-300774
Paul Hewitson, Paul P Glasziou, Les Irwig, Bernie Towler, Eila Watson, Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database of Systematic Reviews. ,vol. 2007, pp. 001216- ,(2007) , 10.1002/14651858.CD001216.PUB2
Cyrus Lemmon, A Reversal of Fortune ,(2011)
Sidney J. Winawer, Ann G. Zauber, May Nah Ho, Michael J. O'Brien, Leonard S. Gottlieb, Stephen S. Sternberg, Jerome D. Waye, Melvin Schapiro, John H. Bond, Joel F. Panish, Frederick Ackroyd, Moshe Shike, Robert C. Kurtz, Lynn Hornsby-Lewis, Hans Gerdes, Edward T. Stewart, Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. The New England Journal of Medicine. ,vol. 329, pp. 1977- 1981 ,(1993) , 10.1056/NEJM199312303292701
David A Lieberman, David G Weiss, John H Bond, Dennis J Ahnen, Harinder Garewal, William V Harford, Dawn Provenzale, Steve Sontag, Tom Schnell, Theodore E Durbin, Doug B Nelson, Steve L Ewing, George Triadafilopoulos, Francisco C Ramirez, John G Lee, Judith F Collins, M Brian Fennerty, Tiina K Johnston, Christopher L Corless, Kenneth R McQuaid, Richard E Sampliner, Thomas G Morales, Ronnie Fass, Robert Smith, Yogesh Maheshwari, Gregorio Chejfec, None, Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer The New England Journal of Medicine. ,vol. 343, pp. 162- 168 ,(2000) , 10.1056/NEJM200007203430301
John M. Inadomi, Why You Should Care about Screening Flexible Sigmoidoscopy New England Journal of Medicine. ,vol. 366, pp. 2421- 2422 ,(2012) , 10.1056/NEJME1204099
Sidney J Winawer, Ann G Zauber, Michael J O'Brien, May Nah Ho, Leonard Gottlieb, Stephen S Sternberg, Jerome D Waye, John Bond, Melvin Schapiro, Edward T Stewart, Joel Panish, Fred Ackroyd, Robert C Kurtz, Moshe Shike, National Polyp Study Workgroup, Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous Polyps The New England Journal of Medicine. ,vol. 328, pp. 901- 906 ,(1993) , 10.1056/NEJM199304013281301
Waldmann A, Katalinic A, Raspe H, [Colon cancer risk in persons at familial or hereditary risk aged < 55 years]. Zeitschrift Fur Gastroenterologie. ,vol. 47, pp. 1052- 1058 ,(2009) , 10.1055/S-0028-1109515